BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15163704)

  • 1. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.
    Boyer PL; Stenbak CR; Clark PK; Linial ML; Hughes SH
    J Virol; 2004 Jun; 78(12):6112-21. PubMed ID: 15163704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
    Lim D; Orlova M; Goff SP
    J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for enzymatic activities of foamy virus protease-reverse transcriptase.
    Schneider A; Peter D; Schmitt J; Leo B; Richter F; Rösch P; Wöhrl BM; Hartl MJ
    Proteins; 2014 Mar; 82(3):375-85. PubMed ID: 23966123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
    Kögel D; Aboud M; Flügel RM
    Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of Substrate Complexes of Foamy Viral Protease-Reverse Transcriptase.
    Nowacka M; Nowak E; Czarnocki-Cieciura M; Jackiewicz J; Skowronek K; Szczepanowski RH; Wöhrl BM; Nowotny M
    J Virol; 2021 Aug; 95(18):e0084821. PubMed ID: 34232702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding.
    Leo B; Schweimer K; Rösch P; Hartl MJ; Wöhrl BM
    Retrovirology; 2012 Sep; 9():73. PubMed ID: 22962864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
    Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
    Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
    Sevilya Z; Loya S; Hughes SH; Hizi A
    J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the protease cleavage site repertoire--the RNase H but not the RT domain is essential for foamy viral protease activity.
    Spannaus R; Bodem J
    Virology; 2014 Apr; 454-455():145-56. PubMed ID: 24725941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic loop of the RNase H domain of MLV RT is important both for RNase H and for polymerase activity.
    Boyer PL; Gao HQ; Frank P; Clark PK; Hughes SH
    Virology; 2001 Mar; 282(1):206-13. PubMed ID: 11259203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
    Julias JG; Ferris AL; Boyer PL; Hughes SH
    J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.
    Kögel D; Aboud M; Flügel RM
    Nucleic Acids Res; 1995 Jul; 23(14):2621-5. PubMed ID: 7544460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
    Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
    Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
    Mbisa JL; Nikolenko GN; Pathak VK
    J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer.
    Misra HS; Pandey PK; Pandey VN
    J Biol Chem; 1998 Apr; 273(16):9785-9. PubMed ID: 9545316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
    Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
    Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
    Goedken ER; Marqusee S
    Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.